BiomX

Phage therapy

Ness Ziona, Israel · Founded 2015 · $56.0M raised

Headquarters
Ness Ziona
Employees
51–200
Founded
2015
Business Model
B2B
Website
biomx.com
Total Funding
$56.0M
Last Round
$32.0M Series BFeb 2019
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

BiomX is building systems focused on detection, aerial systems, and security infrastructure to counter physical threats that are becoming faster, more autonomous, and more complex. Its detection technologies identify, track, and classify physical threats across borders, infrastructure, transportation networks, and other high-consequence sites, while its analysis platforms validate events, prioritize threats, reduce noise, and help operators understand what is happening in real time. The company serves defense, security, and critical-infrastructure customers who need to detect threats sooner and respond faster.

Summary

BiomX is a Biotech company based in Ness Ziona, Israel, founded in 2015. It has raised $56.0M in total across 2 rounds, most recently a $32.0M Series B round in Feb 2019. Investors include Deerfield Management, OrbiMed and Johnson & Johnson Innovation.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingSeries Y Convertible Preferred StockDec 2025
$3.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BiomX on Indexed.vc
<a href="https://indexed.vc/companies/biomx"><img src="https://indexed.vc/api/badge/company/biomx" alt="BiomX on Indexed.vc" width="260" height="76" /></a>